Catalyst Wire Dossier Catalyst Wire Dossier

Nexthaler Dry Powder Inhaler

· Chiesi Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nexthaler Dry Powder Inhaler, covering 2018-04-13 to 2018-04-13. Get the full timeline:

Most recent: Clinical Trial Update: An Open Label Placebo Study to Assess the Inhalation Profile in Asthmatic Patients Using the Nexthaler® Dry Powder Inhaler (DPI) Device [Phase 2]

See pricing